FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2552487941> ?p ?o ?g. }

• W2552487941 endingPage "1203" @default.
• W2552487941 startingPage "1190" @default.
• W2552487941 abstract "// Silvia Baldari 1, * , Alessia Garufi 1, 2, * , Marisa Granato 3 , Laura Cuomo 4 , Giuseppa Pistritto 5 , Mara Cirone 3 , Gabriella D’Orazi 1, 2 1 Department of Research, Advanced Diagnostics, and Technological Innovation, Regina Elena National Cancer Institute, 00144 Rome, Italy 2 Department of Medical Sciences, Tumor Biology Unit, University ‘G. d’Annunzio’, 66013 Chieti, Italy 3 Department of Experimental Medicine, Pasteur-Fondazione Cenci Bolognetti Institute, Sapienza University, 00100 Rome, Italy 4 U.O.C. Clinical Pathology, A.C.O., San Filippo Neri Hospital, 00100 Rome, Italy 5 Department of Systems Medicine, University Tor Vergata, 00133 Rome, Italy * These authors have contributed equally to this work Correspondence to: Gabriella D’Orazi, email: gabriella.dorazi@unich.it Keywords: HIPK2, cancer, hyperglycemia, p53, PP2A Received: August 04, 2016     Accepted: November 08, 2016     Published: November 25, 2016 ABSTRACT Homeodomain interacting protein kinase-2 (HIPK2) is an evolutionary conserved kinase that modulates several key molecular pathways to restrain tumor growth and induce p53-depending apoptotic cell-death in response to anticancer therapies. HIPK2 silencing in cancer cells leads to chemoresistance and cancer progression, in part due to p53 inhibition. Recently, hyperglycemia has been shown to reduce p53 phosphorylation at serine 46 (Ser46), the target residue of HIPK2, thus impairing p53 apoptotic function. Here we asked whether hyperglycemia could, upstream of p53, target HIPK2. We focused on the effect of high glucose (HG) on HIPK2 protein stability and the underlying mechanisms. We found that HG reduced HIPK2 protein levels, therefore impairing HIPK2-induced p53 apoptotic activity. HG-triggered HIPK2 protein downregulation was rescued by both proteasome inhibitor MG132 and by protein phosphatase inhibitors Calyculin A (CL-A) and Okadaic Acid (OA). Looking for the phosphatase involved, we found that protein phosphatase 2A (PP2A) induced HIPK2 degradation, as evidenced by directly activating PP2A with FTY720 or by silencing PP2A with siRNA in HG condition. The effect of PP2A on HIPK2 protein degradation could be in part due to hypoxia-inducible factor-1 (HIF-1) activity which has been previously shown to induce HIPK2 proteasomal degradation through several ubiquitin ligases. Validation analysed performed with HIF-1α dominant negative or with silencing of Siah2 ubiquitin ligase clearly showed rescue of HG-induced HIPK2 degradation. These findings demonstrate how hyperglycemia, through a complex protein cascade, induced HIPK2 downregulation and consequently impaired p53 apoptotic activity, revealing a novel link between diabetes/obesity and tumor resistance to therapies." @default.
• W2552487941 created "2016-11-30" @default.
• W2552487941 creator A5000153354 @default.
• W2552487941 creator A5003089486 @default.
• W2552487941 creator A5005629177 @default.
• W2552487941 creator A5021646795 @default.
• W2552487941 creator A5043662056 @default.
• W2552487941 creator A5063049093 @default.
• W2552487941 creator A5068125261 @default.
• W2552487941 date "2016-11-25" @default.
• W2552487941 modified "2023-09-26" @default.
• W2552487941 title "Hyperglycemia triggers HIPK2 protein degradation" @default.
• W2552487941 cites W1546627335 @default.
• W2552487941 cites W1759625277 @default.
• W2552487941 cites W1838162872 @default.
• W2552487941 cites W1890805542 @default.
• W2552487941 cites W1900480423 @default.
• W2552487941 cites W1963790048 @default.
• W2552487941 cites W1964037605 @default.
• W2552487941 cites W1965506385 @default.
• W2552487941 cites W1968149863 @default.
• W2552487941 cites W1969674563 @default.
• W2552487941 cites W1982897054 @default.
• W2552487941 cites W1983738999 @default.
• W2552487941 cites W1989718925 @default.
• W2552487941 cites W1996857839 @default.
• W2552487941 cites W2005034482 @default.
• W2552487941 cites W2012476805 @default.
• W2552487941 cites W2018304918 @default.
• W2552487941 cites W2022295602 @default.
• W2552487941 cites W2025404088 @default.
• W2552487941 cites W2033453582 @default.
• W2552487941 cites W2036518178 @default.
• W2552487941 cites W2039788380 @default.
• W2552487941 cites W2044842369 @default.
• W2552487941 cites W2048679209 @default.
• W2552487941 cites W2054311839 @default.
• W2552487941 cites W2056210627 @default.
• W2552487941 cites W2057537453 @default.
• W2552487941 cites W2059384319 @default.
• W2552487941 cites W2059612417 @default.
• W2552487941 cites W2063822655 @default.
• W2552487941 cites W2064216090 @default.
• W2552487941 cites W2074650140 @default.
• W2552487941 cites W2077954885 @default.
• W2552487941 cites W2086439732 @default.
• W2552487941 cites W2090693016 @default.
• W2552487941 cites W2091068407 @default.
• W2552487941 cites W2091805259 @default.
• W2552487941 cites W2093257411 @default.
• W2552487941 cites W2098134455 @default.
• W2552487941 cites W2101085456 @default.
• W2552487941 cites W2112311640 @default.
• W2552487941 cites W2114585931 @default.
• W2552487941 cites W2118177072 @default.
• W2552487941 cites W2125296522 @default.
• W2552487941 cites W2130127302 @default.
• W2552487941 cites W2138121862 @default.
• W2552487941 cites W2138774465 @default.
• W2552487941 cites W2139576101 @default.
• W2552487941 cites W2140580306 @default.
• W2552487941 cites W2156784257 @default.
• W2552487941 cites W2156939833 @default.
• W2552487941 cites W2160340008 @default.
• W2552487941 cites W2164006393 @default.
• W2552487941 cites W2170366124 @default.
• W2552487941 cites W2282635561 @default.
• W2552487941 cites W2408954743 @default.
• W2552487941 cites W2469148595 @default.
• W2552487941 cites W2526235182 @default.
• W2552487941 cites W2540617297 @default.
• W2552487941 doi "https://doi.org/10.18632/oncotarget.13595" @default.
• W2552487941 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5352047" @default.
• W2552487941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27901482" @default.
• W2552487941 hasPublicationYear "2016" @default.
• W2552487941 type Work @default.
• W2552487941 sameAs 2552487941 @default.
• W2552487941 citedByCount "18" @default.
• W2552487941 countsByYear W25524879412017 @default.
• W2552487941 countsByYear W25524879412019 @default.
• W2552487941 countsByYear W25524879412020 @default.
• W2552487941 countsByYear W25524879412021 @default.
• W2552487941 countsByYear W25524879412022 @default.
• W2552487941 countsByYear W25524879412023 @default.
• W2552487941 crossrefType "journal-article" @default.
• W2552487941 hasAuthorship W2552487941A5000153354 @default.
• W2552487941 hasAuthorship W2552487941A5003089486 @default.
• W2552487941 hasAuthorship W2552487941A5005629177 @default.
• W2552487941 hasAuthorship W2552487941A5021646795 @default.
• W2552487941 hasAuthorship W2552487941A5043662056 @default.
• W2552487941 hasAuthorship W2552487941A5063049093 @default.
• W2552487941 hasAuthorship W2552487941A5068125261 @default.
• W2552487941 hasBestOaLocation W25524879411 @default.
• W2552487941 hasConcept C121608353 @default.
• W2552487941 hasConcept C126322002 @default.
• W2552487941 hasConcept C184235292 @default.
• W2552487941 hasConcept C190283241 @default.
• W2552487941 hasConcept C502942594 @default.

• next